NHU(SZ:002001)2023-10-20 01:42Group 1: Company Performance and Projects - The company's methionine project is currently in a phased trial run, showcasing a strong profit margin maintained by Shandong Amino Acid Company since 2005 [1] - The company has developed a fully autonomous, large-scale, green, and integrated solid methionine production facility, overcoming key foreign technologies since 2017 [1] - The demand for vitamin products is recovering, with expectations for price increases as downstream aquaculture profitability improves [2] Group 2: Strategic Development and Innovation - The company adheres to an innovation-driven development strategy, focusing on "chemicals+" and "biological+" as its main strategic directions [2] - Future growth will stem from integrated, series, and collaborative development strategies, enhancing research and application service capabilities [2] - The company plans to strengthen cost control across production, supply, sales, research, and finance to improve product competitiveness [2] Group 3: Financial Planning and Shareholder Returns - The company will arrange capital expenditure plans based on project investment situations, maintaining a stable profit distribution policy and cash dividend plan to reward shareholders [2] - High capital expenditures and dividends have been consistent in recent years, reflecting the company's commitment to investor trust and support [2]